
Sign up to save your podcasts
Or
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.
CME: Take the CME Post-Test for this Episode
Published On: 04/01/2024
Duration: 12 minutes, 47 second
Chris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
4.7
489489 ratings
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.
CME: Take the CME Post-Test for this Episode
Published On: 04/01/2024
Duration: 12 minutes, 47 second
Chris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
142 Listeners
1,317 Listeners
1,134 Listeners
610 Listeners
3,336 Listeners
154 Listeners
1,333 Listeners
710 Listeners
293 Listeners
360 Listeners
468 Listeners
720 Listeners
235 Listeners
178 Listeners
138 Listeners